U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919393) titled '"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL' on Feb. 25, 2021.
Brief Summary: It is a multicenter, non-interventional, non pharmacological, translational, prospective study. Any decision about drug administration is made by the physician based on his clinical judgment in the context of clinical practice, independently from the decision to include the patient in the study.
Study Start Date: Oct. 23, 2019
Study Type: OBSERVATIONAL
Condition:
Leukemia, Lymphoblastic
Intervention:
OTHER: "Triple negative" adul B-cell ALL
Samples will be studied with conventional techniques to classify and define prop...